started down the path of collating historical Related Party Transaction amounts and found these gems
2018 Annual Report - just when everyone was celebrating the $100m sales growth that was going to come from expansion into China via signing with Careline
Interesting:
soft Revenue and EBITDA targets only, no setting the bar of achieving NPAT !!
chaaa chiiiing
2016 Annual Report - selling private companies to FOD shareholders
Gross Profit, EBITDA, $2m Marketing Spend !!! - where's the focus upon producing Net Profit for Shareholders ?
And then remember later in 2016 (FY2017 year) the Board voted down the acquisition of another Matt Bailey private company as being overpriced and at a bad time for the FOD share price and the extra dilution effect it would create
I'm starting to see a bit of a pattern here .......
Can we get the 2016 Board back do you reckon ?
Ann: Appendix 4C Cash Flow Report, page-9
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OJC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.015(10.3%) |
Mkt cap ! $47.40M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 16.0¢ | 14.0¢ | $12.92K | 84.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27500 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 10250 | 2 |
View Market Depth
| Last trade - 14.13pm 16/08/2024 (20 minute delay) ? |
| OJC (ASX) Chart |